Production (Stage)
Microbot Medical Inc.
MBOT
$2.62
-$0.02-0.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.70% | -7.55% | -31.44% | -7.78% | 16.89% |
| Total Depreciation and Amortization | -46.43% | -25.71% | 15.00% | -46.15% | 12.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -43.49% | -88.47% | 5.64% | -2.93% | 17.66% |
| Change in Net Operating Assets | -2.64% | 220.31% | -69.90% | 146.97% | 30.26% |
| Cash from Operations | -18.76% | 7.14% | -66.71% | -5.56% | 24.45% |
| Capital Expenditure | 7.14% | -240.00% | 100.00% | 60.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,854.09% | -49.15% | 105.50% | 192.61% | -144.05% |
| Cash from Investing | -1,833.80% | -49.44% | 105.44% | 191.58% | -144.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,060.03% | -- | -- | -69.13% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,060.03% | -- | 493.17% | -69.13% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.80% | 132.04% | 54.74% | -63.50% | -308.44% |